ISRCTN63723433已完成未知
Testing a theory-based intervention designed to increase chronic low back pain patients adherence to physiotherapists recommendations
Health Research Board (HRB) (Ireland)0 个研究点目标入组 292 人开始时间: 2012年1月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 292
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Between 18-70 years
- •2. Low back pain (LBP) of mechanical origin with/without radiation to the lower limb
- •3. Chronic (=3 months)
- •4. English speaking and English literate
- •5. Access to a telephone
排除标准
- •1. Spinal surgery or history of systemic/inflammatory disease
- •2. Scheduled for major surgery during treatment
- •3. Received treatment for CLBP within previous 3 months
- •4. Suspected or confirmed pregnancy
- •5. Unstable angina/uncontrolled cardiac dysrhythmias/severe aortic stenosis/acute systemic infection accompanied by fever
- •6. Patients with acute (< 6 weeks) or subacute LBP (6-12 weeks)
研究者
相似试验
已完成
不适用
Feasibility trial of a structured intervention for expanding social networks in psychosisSpecialty: Mental Health, Primary sub-specialty: PsychosisUKCRC code/ Disease: Mental health/ Organic, including symptomatic, mental disordersMental and Behavioural DisordersUnspecified nonorganic psychosisISRCTN93047402oclor, East London NHS Foundation Trust36
进行中（未招募）
1 期
A proof of concept study to evaluate treatments´efficacy by monitoring Minimal Residual Disease using ctDNA in HR-positive/HER2-negative early breast cancer populatioEarly-stage, Hormone Receptor (HR)-positive / Human Epidermal Growth Factor Receptor 2 (HER2)-negative, breast cancer (BC)CTIS2023-505661-89-00Medica Scientia Innovation Research S.L.1,260
已完成
不适用
Intervention to test the feasibility and effectiveness of sweetness preference reduction in relation to hot beveragesISRCTN56753033niversity College London90
已完成
不适用
Investigating the effectiveness of visual illusions in treating paiISRCTN64093359Royal United Hospitals Bath NHS Foundation Trust88
进行中（未招募）
2 期
Study to evaluate treatment efficacy by monitoring minimal residual disease in an early breast cancer populatioCancerEarly breast cancerISRCTN50261938Medica Scientia Innovation Research, S.L. (MEDSIR)1,260